Ana B. Remirez
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A mouse model to assess immunotherapy-related colitis.
Journal: Methods in cell biology
Published: January 25, 2025
Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors.
Journal: Molecular cancer
Published: January 17, 2025
The C5a/C5aR1 Axis Promotes Migration of Tolerogenic Dendritic Cells to Lymph Nodes, Impairing the Anticancer Immune Response.
Journal: Cancer immunology research
Published: March 15, 2024
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis.
Journal: Cancer letters
Published: October 22, 2021
SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation.
Journal: Journal for immunotherapy of cancer
Published: January 12, 2021
A model based on the quantification of complement C4c, CYFRA 21-1 and CRP exhibits high specificity for the early diagnosis of lung cancer.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: October 26, 2020
TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients.
Journal: Journal of clinical medicine
Published: October 09, 2019
YES1 Drives Lung Cancer Growth and Progression and Predicts Sensitivity to Dasatinib.
Journal: American journal of respiratory and critical care medicine
Published: June 06, 2019
The oncogenic RNA-binding protein SRSF1 regulates LIG1 in non-small cell lung cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: May 14, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026